Many experts see antibody testing as a key to re-opening the economy. But significant problems remain with these tests that mean we may not be able to rely on them...
Read More
A coronavirus vaccine is likely our best option for life to return to normal. Yes, we will find treatments that will ease the burden on the health care system. We...
Read More
When you think of security you might imagine security cameras, alarm systems, and guards. But security is so much more than that, especially for clinical trials. Security in clinical trials...
Read More
The novel coronavirus is sweeping across the globe and straining health care systems in almost every country. The usual clinical trial process for developing treatments will not suffice for a...
Read More
Health Canada has put forth specific guidelines for clinical sponsors for the management of clinical trials during the COVID-19 pandemic. These are stressful times for many but we are ensuring...
Read More
You start to feel a tickle in the back of your throat. It turns into a full-blown cough. Then you develop a fever. You shake and get chills as you...
Read More
Coronavirus is the topic on many peoples’ minds right now as the number of cases continue to climb. Multiple companies are working hard to develop and test a vaccine for...
Read More
Bay Area Research Logistics (BARL) would like to assure our clients that product quality and patient safety is of the utmost importance to our company and our employees. The development...
Read More
The success of a clinical trial often depends on attracting the appropriate participants so that the sample reflects the general population. But how to ensure that this is the case? We’ve found some of the major problems with clinical trial diversity and how to solve them. Who is Represented? Studies indicate that many trials under-represent women, people of colour, and…
2019 was an exciting year for the clinical trial and medical community with some major breakthroughs and news. Here are the top 5 groundbreaking happenings that caught our attention this...
Read More
